Search

Background: Consonant clusters are a feature of many world languages. The acquisition of consonant clusters is one of the latest occurring aspects of speech acquisition in normally developing children. Difficulty producing consonant clusters has been found to contribute to high levels of unintelligibility in children with phonological impairment. Results: Age of suppression of cluster reduction in Egyptian children was found to be between 3 years 6 months and 4 years. There was a gradual decrease in frequency of occurrence of cluster reduction from 74% (2 years 6 months–3 years) to 46% (3 years–3 years 6 months) to 10% (3 years 6 months–4 years). There was significant statistical association between consonant clusters of obstruents + sonorants (stops + sonorants and fricatives + sonorants) between the different age groups (pvalue < 0.001). Both techniques of therapy showed significant improvement of post-therapy score. There was no significant difference between total intervention duration in both techniques; however, there was significant association between cumulative intervention intensity and minimal contrast therapy (pvalue < 0.001). Conclusion: The Egyptian Monosyllabic Consonant Cluster Test (EMCCT) is a valid and reliable assessment tool for identification of percentage of occurrence of cluster reduction process. Both minimal contrast and auditory bombardment approaches are applicable for cluster reduction remediation.

The objective of this study was to isolate the potential fungal isolates have the ability for gluconic acid production by using some agro industrial byproducts as sugarcane molasses, banana-must and grape-must. The effect of gamma-irradiation on the most potent isolates and the fermentation conditions as pH, incubation temperature and incubation period was also investigated. Results showed that the most potential fungal isolates were Aspergillus niger, Penicillium puberulumand Penicillium frequentanswhereas their gluconic acid production was 62.17, 56.25 and 39.69 g/L, respectively on Czapek's Dox media at 28 ± 1 °C, pH 6 for 7 days fermentation period. Irradiation of the three most potential isolates at 0.1, 0.2, 0.3, 0.4 and 0.5 kGy doses of gamma ray showed that 0.1 kGy dose caused an increase in gluconic acid production whereas it was 69.35, 60.17 and 40.31 g/L by the three potential isolates respectively. Data showed that utilization of sugarcane molasses, banana-must and grape-must as a sole carbon source in gluconic acid production by the three potential (0.1 kGy) irradiated isolates at pH 6, 30 °C for a 7 days incubation period caused increasing in gluconic acid production whereas the productivity of the three (0.1 kGy) irradiated isolates (A. niger, P. puberulumand P. frequentans) was 69.87, 63.14 and 51.28 g/L by utilizing sugarcane molasses, 61.28, 56.37, 47.15 g/L by utilizing banana-must and 54.25, 52.75 and 44.75 g/L by utilizing grape-must.

We retrospectively reviewed factors that affected overall survival for patients with gynecological cancers that had metastasized to the brain. Between January 1985 to November 1999, we treated 25 patients with brain metastases from gynecological malignancies (cervix n=6, endometrium n=10, and ovary n=9). Various patient and tumor characteristics were identified and analyzed for their significance. Median age was 46 years old (range, 37–78 years) with the majority of tumors being adenocarcinoma (20/25 patients). The treatment consisted of whole brain radiation therapy (WBRT) in 11 patients, focal therapy (surgery and/or stereotactic radiosurgery [SRS]) in 6 patients, and combination therapy (WBRT and surgery and/or SRS) in 8 patients and resulted in median survivals of 6 months, 7 months and 11 months, respectively. Overall median survival was 7.3 months (range, 1 to 88 months). Cause of death was systemic in 9, neurologic in 8 and progression of primary in 2. Those with single lesions had better median survivals compared to those with multiple lesions (17 months vs. 3 months, p=0.017). Our results suggest that patients with a single lesion had improved outcomes. We encourage enrollment of patients with brain metastases onto prospective clinical trials.

We report the presentation of brain metastases from bladder carcinoma. We investigated the role of whole brain radiation therapy for treating this disease.

Objective.The objective of this study was to investigate the effectiveness of radiation therapy as a treatment for brain metastases from endometrial carcinoma.

It has been reported that interferons (IFNs) may have antitumor activity in multiple myeloma (MM). The mechanism for their effect on MM, however, remains elusive. This study shows that IFN-α and -β, but not -γ, induce apoptosis characterized by Annexin V positivity, nuclear fragmentation and condensation, and loss of clonogenicity in 3 MM cell lines (U266, RPMI-8266, and NCI-H929), and in plasma cells from 10 patients with MM. Apo2 ligand (Apo2L, also TRAIL) induction was one of the earliest events following IFN administration in U266 cells. Treatment of these cells with TRAIL, but not with Fas agonistic antibodies, induces apoptosis. Cell death induced by IFNs and Apo2L in U266 cells was partially blocked by a dominant-negative Apo2L receptor, DR5, demonstrating the functional significance of Apo2L induction. This study shows that IFNs activate caspases and the mitochondrial-dependent apoptotic pathway, possibly mediated by Apo2L production. Thus, IFN-α and -β induce cytochrome c release from mitochondria starting at 12 hours, with an amplified release seen at 48 hours. Moreover, Bid cleavage precedes the initial cytochrome c release, whereas the late, amplified cytochrome c release coincides with changes in levels of Bcl-2, Bcl-XL, and reduction of mitochondrial membrane potential. These results link the Apo2L induction and modulation of Bcl-2 family proteins to mitochondrial dysfunction. Furthermore, IFNs and Apo2L induce cell death of CD38+/CD45−/dimplasma cells, without significant effect on nonplasma blood cells, in a caspase and Bcl-2 cleavage-dependent manner. These results warrant further clinical studies with IFNs and Apo2L in MM.

It has been reported that interferons (IFNs) may have antitumor activity in multiple myeloma (MM). The mechanism for their effect on MM, however, remains elusive. This study shows that IFN-α and -β, but not -γ, induce apoptosis characterized by Annexin V positivity, nuclear fragmentation and condensation, and loss of clonogenicity in 3 MM cell lines (U266, RPMI-8266, and NCI-H929), and in plasma cells from 10 patients with MM. Apo2 ligand (Apo2L, also TRAIL) induction was one of the earliest events following IFN administration in U266 cells. Treatment of these cells with TRAIL, but not with Fas agonistic antibodies, induces apoptosis. Cell death induced by IFNs and Apo2L in U266 cells was partially blocked by a dominant-negative Apo2L receptor, DR5, demonstrating the functional significance of Apo2L induction. This study shows that IFNs activate caspases and the mitochondrial-dependent apoptotic pathway, possibly mediated by Apo2L production. Thus, IFN-α and -β induce cytochrome c release from mitochondria starting at 12 hours, with an amplified release seen at 48 hours. Moreover, Bid cleavage precedes the initial cytochrome c release, whereas the late, amplified cytochrome c release coincides with changes in levels of Bcl-2, Bcl-XL, and reduction of mitochondrial membrane potential. These results link the Apo2L induction and modulation of Bcl-2 family proteins to mitochondrial dysfunction. Furthermore, IFNs and Apo2L induce cell death of CD38+/CD45−/dimplasma cells, without significant effect on nonplasma blood cells, in a caspase and Bcl-2 cleavage-dependent manner. These results warrant further clinical studies with IFNs and Apo2L in MM.

Objective.The aim of this study was to investigate the patterns of brain involvement and the outcome of patients with brain metastases from cervical carcinoma.